|
|
| | 2-[2-(4-Bromophenyl)-1H-benzimidazol-6-yl]-2,3-dihydro-5-(4-morpholinyl)-1H-isoindol-1-one Basic information |
| | 2-[2-(4-Bromophenyl)-1H-benzimidazol-6-yl]-2,3-dihydro-5-(4-morpholinyl)-1H-isoindol-1-one Chemical Properties |
| Boiling point | 754.2±70.0 °C(Predicted) | | density | 1.525±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | solubility | Soluble to 10 mM in DMSO | | pka | 10.31±0.10(Predicted) |
| | 2-[2-(4-Bromophenyl)-1H-benzimidazol-6-yl]-2,3-dihydro-5-(4-morpholinyl)-1H-isoindol-1-one Usage And Synthesis |
| Uses | CDK-IN-11 is a heterocyclic compound that has an action of promoting cardiomyocyte maturation[1]. | | Biological Activity | T 112 is an estrogen-related receptor gamma (ERRγ) agonist. Promotes maturation of hiPSC-derived cardiomyocytes. T 112 accelerates metabolic and sarcomere maturation in cardiomyocytes, as well as maturation of contractile and electrophysiological properties and ultrastructure organization, when used alone or in combination with other small molecules. | | storage | Store at -20°C | | References | [1] Yoshida S, et al. Heterocyclic compound. Japan, JPWO2019189553A1. 2021-03-25. |
| | 2-[2-(4-Bromophenyl)-1H-benzimidazol-6-yl]-2,3-dihydro-5-(4-morpholinyl)-1H-isoindol-1-one Preparation Products And Raw materials |
|